These commenters noted that the measure's administrative tasks, including data collection and tracking, could create significant burden for facilities with existing staff shortages which would divert resources from direct patient care
Merit Pharmaceutical shall not be liable for any damageswhether direct, indirect, incidental, consequential, special, or otherwisearising out of or in connection with the use of, or reliance on, any information provided on this website.
We also proposed that if a hospital waives its right to appeal a CMP and receives a 35 percent reduction in accordance with 180.90(c)(4), the hospital: (1) would not be eligible to receive a 35 percent reduction under 180.90(c)(4) on any subsequent CMPs issued under 180.90(f) that result from the same instance(s) of noncompliance (that is, continuing violations)
Gentle swirling is acceptable, but shaking can denature the peptide and reduce potency
Epub 2024 Sep 10
Pediatr Radiol 44:5055